+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biological Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 4911475
  • Report
  • November 2019
  • Region: Global
  • 232 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A
  • GE Healthcare
  • Guerbet
  • Lantheus Holdings, Inc.
  • Luminex Corporation
Biological Imaging Reagents Market - Scope of the Report

The report on the global biological imaging reagents market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global biological imaging reagents market for the period of 2017 to 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global biological imaging reagents market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involved bulk of the research efforts, wherein, analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global biological imaging reagents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of the top-down and bottom-up approaches to study various phenomena in the global biological imaging reagents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global biological imaging reagents market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global biological imaging reagents market.

The report delves into the competitive landscape of the global biological imaging reagents market. Key players operating in the global biological imaging reagents market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global biological imaging reagents market that have been profiled in this report.

Key Questions Answered in the Biological Imaging Reagents Market Report

  • What is the sales/revenue expected to be generated by each class and modality segment of the biological imaging reagents market across all regions during the forecast period?
  • What are the opportunities in the global biological imaging reagents market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is likely to expand at the fastest CAGR during the forecast period?
  • Which biological imaging reagent class and modality segment are expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What is the market share or position of different companies operating in the global market in 2018?

Biological Imaging Reagents Market - Research Objectives and Research Approach

The comprehensive report on the global biological imaging reagents market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, regulatory scenario, technological advancements, and disease prevalence rate of different diseases and conditions.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of the actual and projected values of key segments is visually appealing to readers. This also allows the comparison of the market shares of key segments in the past and at the end of the forecast period.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A
  • GE Healthcare
  • Guerbet
  • Lantheus Holdings, Inc.
  • Luminex Corporation

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global Biological Imaging Reagents Market
4. Market Overview
4.1. Introduction
4.1.1. Class Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Regulatory Scenario by Region/globally
5.2. Technological Advancements
5.3. Disease Prevalence & Incidence Rate globally with key countries
6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class, 2017–2027
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Class, 2017–2027
6.3.1. Contrast Reagents
6.3.2. Optical Reagents
6.3.3. Nuclear Reagents
6.4. Market Attractiveness, by Class
7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality, 2017–2027
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Modality, 2017–2027
7.3.1. MRI
7.3.2. Ultrasound
7.3.3. X-ray & CT
7.3.4. Nuclear
7.3.4.1. PET
7.3.4.2. SPECT
7.3.5. Optical Imaging
7.3.6. Others
7.4. Market Attractiveness, by Modality
8. Global Biological Imaging Reagents Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2027
8.3.1. In Vitro
8.3.1.1. Proteomics
8.3.1.2. Genomics
8.3.1.3. Cell Biology
8.3.2. In Vivo
8.4. Market Attractiveness, by Application
9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user, 2017–2027
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2027
9.3.1. Diagnostic Laboratories
9.3.2. Imaging Centers
9.3.3. Life Sciences Companies
9.3.4. Academic & Research Institutes
9.3.5. Others
9.4. Market Attractiveness, by End-user
10. Global Biological Imaging Reagents Market Analysis and Forecasts, by Region, 2017–2027
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Country/Region
11. North America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
11.1.Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Class, 2017–2027
11.2.1. Contrast Reagents
11.2.2. Optical Reagents
11.2.3. Nuclear Reagents
11.3. Market Value Forecast, by Modality, 2017–2027
11.3.1. MRI
11.3.2. Ultrasound
11.3.3. X-ray & CT
11.3.4. Nuclear
11.3.4.1. PET
11.3.4.2. SPECT
11.3.5. Optical Imaging
11.3.6. Others
11.4. Market Value Forecast, by Application, 2017–2027
11.4.1. In Vitro
11.4.1.1. Proteomics
11.4.1.2. Genomics
11.4.1.3. Cell Biology
11.4.2. In Vivo
11.5. Market Value Forecast, by End-user, 2017–2027
11.5.1. Diagnostic Laboratories
11.5.2. Imaging Centers
11.5.3. Life Sciences Companies
11.5.4. Academic & Research Institutes
11.5.5. Others
11.6. Market Value Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Class
11.7.2. By Modality
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Class, 2017–2027
12.2.1. Contrast Reagents
12.2.2. Optical Reagents
12.2.3. Nuclear Reagents
12.3. Market Value Forecast, by Modality, 2017–2027
12.3.1. MRI
12.3.2. Ultrasound
12.3.3. X-ray & CT
12.3.4. Nuclear
12.3.4.1. PET
12.3.4.2. SPECT
12.3.5. Optical Imaging
12.3.6. Others
12.4. Market Value Forecast, by Application, 2017–2027
12.4.1. In Vitro
12.4.1.1. Proteomics
12.4.1.2. Genomics
12.4.1.3. Cell Biology
12.4.2. In Vivo
12.5. Market Value Forecast, by End-user, 2017–2027
12.5.1. Diagnostic Laboratories
12.5.2. Imaging Centers
12.5.3. Life Sciences Companies
12.5.4. Academic & Research Institutes
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Class
12.7.2. By Modality
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Class, 2017–2027
13.2.1. Contrast Reagents
13.2.2. Optical Reagents
13.2.3. Nuclear Reagents
13.3. Market Value Forecast, by Modality, 2017–2027
13.3.1. MRI
13.3.2. Ultrasound
13.3.3. X-ray & CT
13.3.4. Nuclear
13.3.4.1. PET
13.3.4.2. SPECT
13.3.5. Optical Imaging
13.3.6. Others
13.4. Market Value Forecast, by Application, 2017–2027
13.4.1. In Vitro
13.4.1.1. Proteomics
13.4.1.2. Genomics
13.4.1.3. Cell Biology
13.4.2. In Vivo
13.5. Market Value Forecast, by End-user, 2017–2027
13.5.1. Diagnostic Laboratories
13.5.2. Imaging Centers
13.5.3. Life Sciences Companies
13.5.4. Academic & Research Institutes
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Class
13.7.2. By Modality
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Class, 2017–2027
14.2.1. Contrast Reagents
14.2.2. Optical Reagents
14.2.3. Nuclear Reagents
14.3. Market Value Forecast, by Modality, 2017–2027
14.3.1. MRI
14.3.2. Ultrasound
14.3.3. X-ray & CT
14.3.4. Nuclear
14.3.4.1. PET
14.3.4.2. SPECT
14.3.5. Optical Imaging
14.3.6. Others
14.4. Market Value Forecast, by Application, 2017–2027
14.4.1. In Vitro
14.4.1.1. Proteomics
14.4.1.2. Genomics
14.4.1.3. Cell Biology
14.4.2. In Vivo
14.5. Market Value Forecast, by End-user, 2017–2027
14.5.1. Diagnostic Laboratories
14.5.2. Imaging Centers
14.5.3. Life Sciences Companies
14.5.4. Academic & Research Institutes
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Class
14.7.2. By Modality
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast, 2017–2027
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Class, 2017–2027
15.2.1. Contrast Reagents
15.2.2. Optical Reagents
15.2.3. Nuclear Reagents
15.3. Market Value Forecast, by Modality, 2017–2027
15.3.1. MRI
15.3.2. Ultrasound
15.3.3. X-ray & CT
15.3.4. Nuclear
15.3.4.1. PET
15.3.4.2. SPECT
15.3.5. Optical Imaging
15.3.6. Others
15.4. Market Value Forecast, by Application, 2017–2027
15.4.1. In Vitro
15.4.1.1. Proteomics
15.4.1.2. Genomics
15.4.1.3. Cell Biology
15.4.2. In Vivo
15.5. Market Value Forecast, by End-user, 2017–2027
15.5.1. Diagnostic Laboratories
15.5.2. Imaging Centers
15.5.3. Life Sciences Companies
15.5.4. Academic & Research Institutes
15.5.5. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Class
15.7.2. By Modality
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Position/Ranking Analysis, by Company (2018)
16.3. Company Profiles
16.3.1. Bayer AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Thermo Fisher Scientific, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. PerkinElmer, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Guerbet
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Lantheus Holdings, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Bracco S.p.A.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. GE Healthcare
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Becton, Dickinson and Company (BD)
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. Siemens Healthineers
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis
16.3.10. Luminex Corporation
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Company Financials
16.3.10.3. Growth Strategies
16.3.10.4. SWOT Analysis
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Guerbet
  • Lantheus Holdings, Inc.
  • Bracco S.p.A
  • GE Healthcare
  • Becton, Dickinson and Company (BD)
  • Siemens Healthineers
  • Luminex Corporation
Note: Product cover images may vary from those shown